Brief Treatment for Posttraumatic Stress Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03033602|
Recruitment Status : Completed
First Posted : January 27, 2017
Last Update Posted : December 17, 2020
|Condition or disease||Intervention/treatment||Phase|
|PTSD||Behavioral: written exposure therapy Behavioral: CPT, cognitive only||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||170 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Brief Treatment for PTSD: Enhancing Retention and Engagement|
|Actual Study Start Date :||July 20, 2015|
|Actual Primary Completion Date :||October 15, 2020|
Experimental: Written exposure therapy
5 sessions of imaginal exposure therapy.
Behavioral: written exposure therapy
five sessions of writing about traumatic experience.
Other Name: WET
Active Comparator: CPT, cognitive only
12 sessions of cognitive therapy.
Behavioral: CPT, cognitive only
12 sessions of cognitive therapy related to traumatic experience.
Other Name: CPT-C
- Clinician Administered PTSD Scale, 5 [ Time Frame: Change from baseline to 10-, 20-, 30-weeks post first treatment session ]PTSD symptom scale
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03033602
|United States, Texas|
|Killeen, Texas, United States|
|University of Texas Health Science Center, San Antonio|
|San Antonio, Texas, United States, 78229|
|Principal Investigator:||Denise Sloan, Ph.D.||Boston VA Research Institute, Inc.|